相关实验视频

Updated: Jun 5, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

2013年至2023年全球多发性骨髓瘤的可视化免疫疗法:一个图书统计分析

Jinqiao Li¹, Xiaoxia Li¹, Yueyue Fu¹

¹Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.

Human vaccines & immunotherapeutics

|December 6, 2024

概括

本文献分析揭示了多发性骨髓瘤 (MM) 免疫治疗研究的关键趋势. 达拉图马布,BCMA CAR-T疗法和双特异性抗体是当前的热点,指导未来的临床实践和对这种不可治愈疾病的研究.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
图书统计学图书统计学

背景情况:

多发性骨髓瘤 (MM) 是一种无法治愈的血细胞恶性瘤.
目前的研究重点是推进MM免疫疗法.
图书统计分析为研究趋势和现状提供了洞察力.

研究的目的:

分析多发性骨髓瘤免疫治疗的研究现状和新兴趋势.
为MM免疫疗法未来的研究和临床实践提供指导.
确定关键的研究热点和合作模式.

主要方法:

从科学网络核心集合 (2013-2023) 中对1,018篇出版物的图书法分析.
使用VOSviewer和CiteSpace进行数据可视化和趋势分析.
确定了领先的国家,机构,研究人员和高度引用的文学作品.

主要成果:

美国和中国在出版物方面处于领先地位.
哈佛大学和研究员安德森KC的生产力非常高.
关键的研究热点包括达拉图马布,BCMA CAR-T疗法和复发性/耐药性MM (RRMM) 管理.
双特异性抗体和临床前活动显示出新兴趋势.

结论:

达拉图马布,BCMA CAR-T疗法和RRMM管理是核心研究领域.
双特异性抗体代表了MM免疫疗法的重要新兴前沿.
建议加强国际,机构和作者合作,以推动该领域的发展.

关键词:

在CART-T中,我们可以使用CAR-T.多发性骨髓瘤是一种多发性骨髓瘤.文献计量分析的分析两种特异性的抗体.在达拉图姆巴姆巴布.免疫疗法免疫疗法

更多相关视频

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...